Landaas & CO Gsk PLC Transaction History

Landaas & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $4,491 - $4,823	-113 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$39.61 - $42.76 $4,475 - $4,831	113 New	113 $5,000
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $3,943 - $4,376	-109 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $7,032 - $8,338	-199 Reduced 64.61%	109 $4,000
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $12,147 - $12,797	308	308 $13,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

Stay updated on Landaas & CO with notifications on news.